A single arm trial of cetuximab, FOLFIRI combined with NK as the second line region in metastatic K-ras positive colorectal cancer: the XQZL001 study
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2668928
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 1:cetuximab, FOLFIRI combined with NK as the second line remedy
Primary outcome(s): disease control rate, DCR;Objective Response Rate
Study Design: Case series
创建时间：
2014-04-15
